Mode
Text Size
Log in / Sign up
N/A N=19 Randomized Double-blind Other

Lens Fitting Evaluation of CooperVision MyDay™ Compared With 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®

Myopia

Enrolled (actual)
19
Serious AEs
0.0%
Results posted
May 2016
Primary outcome: Primary: Conjunctival Staining - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A — 0.42; 0.53; 0.68; 0.47 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
stenfilcon A (Device); delefilcon A (Device); narafilcon A (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
Jun 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Conjunctival Staining - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.97; 0.79; 1.00; 1.29; 1.11; 0.47
PRIMARY
Conjunctival Staining - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.97; 0.79; 1.00; 1.29; 1.11; 0.47
PRIMARY
Conjunctival Indentation - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.05; 0.16; 0.26; 0.08; 0.18; 0.05
PRIMARY
Conjunctival Indentation - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.05; 0.16; 0.26; 0.08; 0.18; 0.05
PRIMARY
Limbal Redness - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
1.08; 1.03; 1.05; 1.34; 1.00; 1.03
PRIMARY
Limbal Redness - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
1.08; 1.03; 1.05; 1.34; 1.00; 1.03
PRIMARY
Corneal Staining Type - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.00; 0.08; 0.00; 0.03; 0.05; 0.08
PRIMARY
Corneal Staining Type - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.00; 0.08; 0.00; 0.03; 0.05; 0.08
PRIMARY
Corneal Staining Extent - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.00; 0.03; 0.00; 0.05; 0.11; 0.03
PRIMARY
Corneal Staining Extent - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.00; 0.03; 0.00; 0.05; 0.11; 0.03
PRIMARY
Corneal Staining Depth - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.00; 0.05; 0.00; 0.05; 0.05; 0.05
PRIMARY
Corneal Staining Depth - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.00; 0.05; 0.00; 0.05; 0.05; 0.05
PRIMARY
Corneal Shape Change - Tangential Radius - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
-0.007; -0.004; 0.009; 0.017
PRIMARY
Corneal Shape Change - Wavefront Error - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0.004; -0.006; -0.006; 0.004
PRIMARY
Lens Fit - Corneal Coverage - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
19; 19; 19; 18; 0; 0
PRIMARY
Lens Fit - Corneal Coverage - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
19; 19; 19; 18; 0; 0
PRIMARY
Lens Fit - Horizontal Centration - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0; 0; 0; 2; 2; 1
PRIMARY
Lens Fit - Horizontal Centration - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0; 0; 0; 2; 2; 1
PRIMARY
Lens Fit - Vertical Centration - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0; 0; 0; 0; 0; 0
PRIMARY
Lens Fit - Vertical Centration - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0; 0; 0; 0; 0; 0
PRIMARY
Lens Fit - Post-blink Movement - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0; 0; 0; 0; 0; 0
PRIMARY
Lens Fit - Post-blink Movement - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
0; 0; 0; 0; 0; 0
PRIMARY
Lens Fit - Tightness on up Gaze Blink Lag - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
16; 17; 17; 13; 3; 2
PRIMARY
Lens Fit - Tightness on up Gaze Blink Lag - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
16; 17; 17; 13; 3; 2
PRIMARY
Lens Fit Overall - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
18; 18; 19; 13; 1; 1
PRIMARY
Lens Fit Overall - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
18; 18; 19; 13; 1; 1
SECONDARY
Pain and Foreign Body Sensation (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
15; 15; 13; 11; 2; 3
SECONDARY
Pain and Foreign Body Sensation (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
15; 15; 13; 11; 2; 3
SECONDARY
Itching Sensation on Insertion (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
15; 17; 18; 16; 4; 2
SECONDARY
Itching Sensation on Removal (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
15; 16; 15; 14; 4; 3
SECONDARY
Red Eye (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
19; 19; 17; 16; 0; 0
SECONDARY
Dryness (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
91.3; 92.5; 93.0; 90.2; 87.8; 87.2
SECONDARY
Comfort (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
90.0; 92.7; 84.3; 84.6; 90.0; 88.4
SECONDARY
Handling (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
95.8; 93.0; 90.9; 91.3; 81.6; 86.4
SECONDARY
Vision (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
90.0; 94.1; 86.5; 90.6; 93.5; 96.8
SECONDARY
Overall Wearing Satisfaction (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
86.5; 88.6; 86.8; 83.4
SECONDARY
Lens Preferences (Subjective Rating) - Stenfilcon A/Delefilcon A and Stenfilcon A/Narafilcon A
7; 11; 15; 4

Summary

Lens Fitting Evaluation of CooperVision MyDay™ Compared with 1-DAY ACUVUE® TruEye® and DAILIES TOTAL1®

Eligibility Criteria

Inclusion Criteria

  • Is between 18 and 40 years of age (inclusive)
  • Has had a self-reported visual exam in the last two years
  • Is an adapted soft spherical contact lens wearer
  • Has a contact lens spherical prescription between -4.00 to - 6.00 and higher than -7.00D (Diopters) (inclusive)
  • Has a BFS (Best Fit Sphere) that is higher than 8.2 measured and calculated by corneal topography
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses
  • Has clear corneas and no active ocular disease
  • Has read, understood and signed the information consent letter
  • Patient contact lens refraction should fit within the available parameters of the study lenses
  • Is willing to comply with the wear schedule
  • Is willing to comply with the visit schedule

Exclusion Criteria

  • Is not a habitual wearer of soft spherical contact lenses
  • Has a contact lens prescription outside the range of the available parameters of the study lenses
  • Has a contact lens prescription outside the range of the inclusion power range
  • Has a spectacle cylinder ≥1.00D of cylinder in either eye
  • Has a history of not achieving comfortable contact lens wear (5 days per week; > 8 hours/day)
  • Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye
  • Presence of clinically significant (grade > 2) anterior segment abnormalities
  • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Moderate to severe dry eye
  • Pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization > 0.75 mm in from of the limbus
  • Giant papillary conjunctivitis (GCP) worse than grade 1
  • Anterior uveitis or iritis (past or present)
  • Seborrheic eczema, Seborrheic conjunctivitis
  • History of corneal ulcers or fungal infections
  • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
  • Has aphakia, keratoconus or a highly irregular cornea
  • Has Presbyopia or has dependence on spectacles for near work over the contact lenses
  • Has undergone corneal refractive surgery
  • Is participating in any other type of eye related clinical or research study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02341859). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search